ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. The company is headquartered in New York City, New York and currently employs 96 full-time employees. The firm is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. The company develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The firm also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.
Mr. Ted Karkus 2009 'den beri şirketle birlikte olan Prophase Labs Inc 'in Chairman of the Board 'ıdır.
PRPH hissesinin fiyat performansı nasıl?
PRPH 'in mevcut fiyatı $0.13 'dir, son işlem günde 0% azalmış etti.
Prophase Labs Inc için ana iş temaları veya sektörler nelerdir?
Prophase Labs Inc Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Prophase Labs Inc 'in piyasa değerlemesi nedir?
Prophase Labs Inc 'in mevcut piyasa değerlemesi $854.1K 'dir
Prophase Labs Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist Prophase Labs Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 4 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir